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This presentation will look at how O-GlcNAcylation affects the activity of succinate
dehydrogenase and how it may be involved in metabolic diseases such as diabetes and obesity.
O-linked N-acetylglucosamine Transferase (OGT) is an enzyme that glycosylates proteins on
serine and threonine residues. O-GlcNAcylation has been shown to play a prominent regulatory
role in a variety of cellular processes, and aberrant O-GlcNAc signaling has been implicated in
human diseases such as obesity and Type II diabetes (1). High glucose levels have been shown to
increase O-GlcNAcylation, which has been connected to diabetes (2). One way in which excess
O-GlcNAcylation may be involved in diabetes is by causing decreased metabolic function. OGlcNAcylation has been shown to occur on complexes I, III, and IV of the electron transport
chain in the mitochondria, and as glucose levels and O-GlcNAcylation increased, mitochondrial
function was impaired (3). This presentation will explore whether this type of modification has
effects on a principal mitochondrial enzyme, succinate dehydrogenase (SDH), which is involved
both in catalyzing the conversion of succinate to fumarate in the TCA cycle and is a part of
complex II in the electron transport chain. Key O-GlcNAcylation sites on SDH were mutated,
then transfected into Hela cells. An enzymatic assay was performed to examine the effects of OGlcNAcylation on SDH activity by using the reduction of DCPIP. The SDH with a double
mutation appeared to have decreased activity, suggesting that some O-GlcNAcylation is required
for the function of SDH.
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